NCT Number: NCT06193486
Phase: PHASE1
Trial Summary: This is a phase 1 single center clinical trial for patients with end stage Metastatic Castration Resistant Prostate Cancer who have progressed through standard of care treatment options and are on zol – see clinicaltrials.gov for information and location
Clinicaltrials.gov
Trial Sponsor(s): H. Lee Moffitt Cancer Center and Research Institute
Acronym:
Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives